Pharmaceutical
Upcoming Earnings
Biopharmaceutical
Bristol-Myers Squibb
$43.049876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$43.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.28 (0.65%) Today
-$0.01 (-0.02%) As of 7:51 PM EDT after-hours
Why Robinhood?
You can buy or sell BMY and other stocks, options, ETFs, and crypto commission-free!
About BMY
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. Read More The company was founded in August 1933 and is headquartered in New York, NY.
Employees
23,300
Headquarters
New York, New York
Founded
1933
Market Cap
69.96B
Price-Earnings Ratio
13.52
Dividend Yield
3.10
Average Volume
12.47M
High Today
$43.07
Low Today
$42.48
Open Price
$42.81
Volume
17.66M
52 Week High
$63.69
52 Week Low
$42.48
Collections
Pharmaceutical
Upcoming Earnings
Biopharmaceutical
Manufacturing
Research And Development
Health
Biotechnology
Technology
BMY News
Price Paid on Robinhood
13% Lower
Right Now
52 Week Low
$44.30
Average Price Paid
$49.37
52 Week High
$63.69
Analyst Ratings
46%
of 13 ratings
Buy
46%
Hold
54%
Sell
0%
BMY Earnings
$0.67
$0.81
$0.96
$1.10
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
$1.06 per share
Actual
Available Jul 25, Pre-Market